Sanghee Hong (@hongsmd) 's Twitter Profile
Sanghee Hong

@hongsmd

Leukemia/BMT specialist at Duke

ID: 805181843544752129

calendar_today03-12-2016 22:48:05

52 Tweet

76 Followers

82 Following

Navneet Majhail, MD, MS (@bldcancerdoc) 's Twitter Profile Photo

πŸ‘ work by #CleClinicBMT fellow ⁦Sanghee Hong⁩ et al: Psychosocial Assessment of Candidates for Transplant (PACT) as a tool for psychological and social evaluation of allogeneic hematopoietic cell transplantation recipients ⁦Bone Marrow Transplantation⁩ nature.com/articles/s4140…

Navneet Majhail, MD, MS (@bldcancerdoc) 's Twitter Profile Photo

😎 thing about in person #ASH21 meeting is the ability to meet and interact with 🌟 trainees (tho this Gen X’er had to take the 🀳 πŸ€·β€β™‚οΈ)

😎 thing about in person #ASH21 meeting is the ability to meet and interact with 🌟 trainees (tho this Gen X’er had to take the 🀳 πŸ€·β€β™‚οΈ)
Navneet Majhail, MD, MS (@bldcancerdoc) 's Twitter Profile Photo

#ASH21 βœ… out our poster on resource utilization of Omidubicel vs cord blood #BMT today at 6 pm ativsoftware.com/appinfo.php?pa… #ASH21

#ASH21 βœ… out our poster on resource utilization of Omidubicel vs cord blood #BMT today at 6 pm ativsoftware.com/appinfo.php?pa… #ASH21
Navneet Majhail, MD, MS (@bldcancerdoc) 's Twitter Profile Photo

In light of ⁦NEJM⁩ study on #VitD, about time we do a solid RCT in #BMT to address this issue; surfacing review by ⁦Sanghee Hong⁩ et al ⁦Bone Marrow Transplantation⁩ To D or not to D: vitamin D in hematopoietic cell transplantation nature.com/articles/s4140…

Anand Patel (@anand_88_patel) 's Twitter Profile Photo

The Phase 3 study of Gilt + Aza vs Aza in newly-dx FLT3m AML in pts that could not receive intensive chemo is out in Blood Journal ! #leusm -mOS 9.82 mon Gilt + Aza and 8.87 mon Aza (p=.75) -similar CR rates: Gilt + aza 16.2%, Aza 14.3% ashpublications.org/blood/article/…

The Phase 3 study of Gilt + Aza vs Aza in newly-dx FLT3m AML in pts that could not receive intensive chemo is out in <a href="/BloodJournal/">Blood Journal</a> ! #leusm
-mOS 9.82 mon Gilt + Aza and 8.87 mon Aza (p=.75)
-similar CR rates: Gilt + aza 16.2%, Aza 14.3%

ashpublications.org/blood/article/…
Melissa Hagemann (@melhagemann) 's Twitter Profile Photo

Today the The White House announced that all federally funded research will be made openly available. Importantly, it eliminates the 12-month embargo. This is the result of decades of work by SPARC, Peter Suber (@[email protected]), Michael Eisen, and so many more. #OpenAccess whitehouse.gov/ostp/news-upda…

ASTCT (@astct) 's Twitter Profile Photo

Join the Education Committee this Thursday, March 23, for the next #ASTCTChat. Starting at 9 AM CT, questions will be posted hourly on Twitter. Join in the conversation using #ASTCTChat: ow.ly/8Pce50Nlzxa

Join the Education Committee this Thursday, March 23, for the next #ASTCTChat. Starting at 9 AM CT, questions will be posted hourly on Twitter. Join in the conversation using #ASTCTChat: ow.ly/8Pce50Nlzxa
Institute for Experimental Cell Therapy, UK-Essen (@iztfe) 's Twitter Profile Photo

We are happy to share Prof. Fleischhauer's commentary on this very relevant study by our CIBMTR colleagues, now available in Transplantation and Cellular Therapy Journal. Incorporating #HLA-DP permissive mismatches results in optimal likelihoods of finding well-matched unrelated donors for our #HCT patients!

We are happy to share Prof. Fleischhauer's commentary on this very relevant study by our <a href="/CIBMTR/">CIBMTR</a> colleagues, now available in <a href="/ASTCT_Journal/">Transplantation and Cellular Therapy Journal</a>. Incorporating #HLA-DP permissive mismatches results in optimal likelihoods of finding well-matched unrelated donors for our #HCT patients!
CIBMTR (@cibmtr) 's Twitter Profile Photo

A study of 567 people who were alive and cancer-free 1 year after #BMT found that most were highly confident about knowledge in their survivorship. Learn more about this CIBMTR study: cibmtr.org/Files/Patient-…

A study of 567 people who were alive and cancer-free 1 year after #BMT found that most were highly confident about knowledge in their survivorship. Learn more about this CIBMTR study: cibmtr.org/Files/Patient-…